Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4Q442
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.569 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.257 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.569 |
CLV_PCSK_PC1ET2_1 | 110 | 112 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.282 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.535 |
DEG_SCF_FBW7_1 | 194 | 201 | PF00400 | 0.483 |
DEG_SCF_FBW7_1 | 54 | 61 | PF00400 | 0.576 |
DOC_CYCLIN_yCln2_LP_2 | 14 | 17 | PF00134 | 0.525 |
DOC_MAPK_gen_1 | 69 | 78 | PF00069 | 0.401 |
DOC_PP2B_LxvP_1 | 14 | 17 | PF13499 | 0.525 |
DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.371 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.424 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.474 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.571 |
LIG_APCC_ABBA_1 | 182 | 187 | PF00400 | 0.402 |
LIG_BRCT_BRCA1_1 | 129 | 133 | PF00533 | 0.379 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.396 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.502 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.449 |
LIG_FHA_2 | 136 | 142 | PF00498 | 0.420 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.457 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 92 | 97 | PF02991 | 0.503 |
LIG_SH2_NCK_1 | 60 | 64 | PF00017 | 0.540 |
LIG_SH2_STAP1 | 204 | 208 | PF00017 | 0.511 |
LIG_SH2_STAT3 | 38 | 41 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.556 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.534 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.502 |
LIG_SH3_3 | 186 | 192 | PF00018 | 0.483 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.759 |
LIG_SUMO_SIM_anti_2 | 143 | 148 | PF11976 | 0.353 |
LIG_SUMO_SIM_par_1 | 102 | 109 | PF11976 | 0.457 |
LIG_WW_3 | 63 | 67 | PF00397 | 0.575 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.581 |
MOD_CK2_1 | 135 | 141 | PF00069 | 0.423 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.600 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.359 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.564 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.409 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.430 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.447 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.561 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.457 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.573 |
MOD_NEK2_2 | 145 | 150 | PF00069 | 0.396 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.654 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.447 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.576 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.508 |
TRG_ER_diArg_1 | 65 | 67 | PF00400 | 0.579 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P505 | Leptomonas seymouri | 72% | 100% |
A0A3Q8IC83 | Leishmania donovani | 37% | 95% |
A0A3S7X6S0 | Leishmania donovani | 98% | 100% |
A4HLK6 | Leishmania braziliensis | 84% | 100% |
A4I287 | Leishmania infantum | 37% | 95% |
A4I917 | Leishmania infantum | 98% | 100% |
E9B3Y2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |